Developer docs
API playgroundTry for free, no card

Search company profiles

Grupo Diagnóstico Médico PROA S.A. de C.V

Full company profile

uuid02m2hbb

Namestring
Grupo Diagnóstico Médico PROA S.A. de C.V
Legal namestring
Grupo Diagnóstico Médico Proa, S.A. de C.V.
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Grupo Diagnóstico Médico PROA S.A. de C.V. is a Mexican privately-held clinical reference laboratory group that operates under the CARPERMOR brand, established in Mexico City in 1996 (with operational experience extending back to 1993 per firmographic records). The company provides specialized diagnostic testing services to healthcare institutions, private hospitals, clinical laboratories, occupational medicine clinics, healthcare integrators, individual physicians, and clinical researchers across Mexico through a national network of 23 analytical centers. With 28+ years of operational experience and more than 84 million studies performed annually, CARPERMOR offers over 2,600 clinical studies across nine specialty areas: molecular biology/genetics/genomics, cytogenetics and cytogenomics, hematology and flow cytometry, immunology and infectology, immunochemistry, microbiology and parasitology, toxicology and instrumental bioanalysis, histopathology and cytology, and urinalysis.

The company's technical infrastructure includes advanced molecular diagnostic platforms (standard PCR, multiplex PCR, RT-PCR, real-time qPCR, PCR-RFLP, FISH), EuroFlow-standardized immunophenotyping panels for hematological malignancies, automated microbiology systems (Vitek 2 XL, Bact/ALERT 3D, PREVI Isola, PREVI Color), LC-MS/MS and GC-MS toxicology instrumentation, FACS CANTO II and FC-500 flow cytometers, and karyotyping capabilities at up to 950 bands resolution using a Carl Zeiss Axio Imager Z2 automated microscope. The company holds three significant international accreditations: CAP accreditation from the College of American Pathologists (the only laboratory in Mexico with full CAP accreditation in microbiology testing), ISO 15189 accreditation from Entidad Mexicana de Acreditación (EMA), and NGSP Level 1 certification for HbA1c testing.

CARPERMOR operates a B2B professional services revenue model, with direct enterprise field sales targeting healthcare institutions, laboratories, occupational medicine providers, insurance integrators, physicians, and clinical researchers across six customer segments under a horizontal segmentation approach. Pricing is not publicly disclosed and services are delivered through direct advisory relationships positioning CARPERMOR as a strategic diagnostic partner. The company markets through a multi-channel approach including its corporate website (carpermor.com.mx), LinkedIn, Twitter, Instagram, YouTube, annual research conferences (XXVI Jornadas CARPERMOR in 2024), digital webinars and seminars, email newsletters, and educational blog content, and it also operates CarperNet, an online client portal for remote laboratory results access.

Short descriptiontext

Mexican clinical reference laboratory group operating the CARPERMOR brand with 23 analytical centers nationwide, delivering 2,600+ specialized diagnostic tests across nine specialties to hospitals, laboratories, occupational medicine clinics, physicians, and clinical researchers.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersMexico City, Mexico
HQ citystring
Mexico City
HQ countrystring
Mexico
HQ regionstring
Latin America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical reference laboratory, diagnostic testing services, molecular diagnostics, medical laboratory services, pathology and cytogenetics
Industry3 codes
1Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryYes
2Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryNo
3Microbiology & Infectious Disease Testing (Trial Support)
CodeHLAGAEAFPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Testing Services
TypeProfessional Services
Description

Laboratory diagnostic services providing 2,600+ clinical studies across specialties including molecular biology, genetics, hematology, immunology, microbiology, and toxicology. Services delivered to hospitals, laboratories, occupational medicine clinics, and physicians.

carpermor.com.mx
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1CarperNet
Description

Client portal for consulting laboratory results online

carpermor.com.mx
+1 more record
Core offering1 text field

Grupo Diagnóstico Médico PROA S.A. de C.V. operates CARPERMOR, a Mexican clinical reference laboratory providing more than 2,600 specialized diagnostic studies across molecular biology, genetics, cytogenetics, hematology, immunology, microbiology, toxicology, histopathology and immunochemistry. Services are delivered through 23 analytical centers nationwide to hospitals, private laboratories, occupational medicine clinics, integrators/insurers, physicians, and clinical researchers, supported by CAP, ISO 15189 and NGSP Level 1 quality accreditations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 84+ million studies performed annually with quality assurance
+2 more records
Product overview1 text field

CARPERMOR is a clinical reference laboratory operating as a single unified service with 23 analytical centers across Mexico. The portfolio comprises nine core specialty testing services: Clinical Laboratory Services (core offering), Toxicology and Instrumental Bioanalysis, Microbiology and Parasitology, Immunochemistry, Hematology and Flow Cytometry, Cytogenetics and Cytogenomics, Molecular Biology/Genetics/Genomics, Histopathology and Cytology, Immunology and Infectology, and Urinalysis. Together these specialties offer more than 2,600 diagnostic studies and tests, supported by a quality management system accredited by CAP and ISO 15189.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1LABIN / Laboratorio de Análisis Clínicos
TypeDirect peer
Description

Mexican clinical laboratory operator with multiple branches offering routine and specialized diagnostic testing. Comparable horizontal B2B/B2C model and multi-specialty menu.

TypeDirect peer
Description

Mexican clinical reference lab group with multiple branches providing diagnostic testing to physicians, hospitals and patients. Comparable to CARPERMOR in geographic focus (Mexico), service mix and B2B go-to-market.

3Laboratorios Chopo
TypeDirect peer
Description

One of Mexico's largest independent clinical laboratory chains, offering a broad test menu to walk-in and B2B customers nationwide. Closest direct competitor to CARPERMOR by service model, scale and target segments.

TypeDirect peer
Description

Mexico-based clinical laboratory network with broad ambulatory and B2B testing services. Competes with CARPERMOR for physician referrals and hospital send-out work in the Mexican market.

TypeBroad incumbent
Description

U.S.-headquartered global reference lab with extensive esoteric testing, broad routine menu and B2B hospital/physician channels. Sets competitive benchmark on scale, automation and international accreditations that CARPERMOR emulates in Mexico.

TypeRegional player
Description

Large emerging-market clinical reference lab headquartered in India, serving physicians, hospitals and pharma sponsors with broad esoteric and routine testing. Comparable as an international (non-Mexico) reference lab peer pursuing similar growth drivers.

TypeBroad incumbent
Description

European-headquartered clinical reference laboratory operating in over 30 countries with broad routine and specialty menus. Comparable central-lab and clinical-research services model and accreditation profile.

TypeBroad incumbent
Description

Global medical diagnostics operator with national reference laboratory networks across multiple geographies. Comparable in providing accredited central-lab services to hospitals, physicians and occupational-medicine clients.

TypeBroad incumbent
Description

Large global clinical laboratory and diagnostics company with central-lab capabilities serving hospitals, physicians and clinical trials. Comparable in central-lab services for pharma research that CARPERMOR also pursues.

TypeBroad incumbent
Description

Global group with a strong clinical diagnostics arm offering reference lab and specialty testing across many countries. Relevant comparable for CARPERMOR's specialty testing (microbiology, genomics) and clinical trial central lab work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Grupo Diagnóstico Médico PROA S.A. de C.V

Mexican clinical reference laboratory group operating the CARPERMOR brand with 23 analytical centers nationwide, delivering 2,600+ specialized diagnostic tests across nine specialties to hospitals, laboratories, occupational medicine clinics, physicians, and clinical researchers.

What Grupo Diagnóstico Médico PROA S.A. de C.V does

Grupo Diagnóstico Médico PROA S.A. de C.V. is a Mexican privately-held clinical reference laboratory group that operates under the CARPERMOR brand, established in Mexico City in 1996 (with operational experience extending back to 1993 per firmographic records). The company provides specialized diagnostic testing services to healthcare institutions, private hospitals, clinical laboratories, occupational medicine clinics, healthcare integrators, individual physicians, and clinical researchers across Mexico through a national network of 23 analytical centers. With 28+ years of operational experience and more than 84 million studies performed annually, CARPERMOR offers over 2,600 clinical studies across nine specialty areas: molecular biology/genetics/genomics, cytogenetics and cytogenomics, hematology and flow cytometry, immunology and infectology, immunochemistry, microbiology and parasitology, toxicology and instrumental bioanalysis, histopathology and cytology, and urinalysis.

The company's technical infrastructure includes advanced molecular diagnostic platforms (standard PCR, multiplex PCR, RT-PCR, real-time qPCR, PCR-RFLP, FISH), EuroFlow-standardized immunophenotyping panels for hematological malignancies, automated microbiology systems (Vitek 2 XL, Bact/ALERT 3D, PREVI Isola, PREVI Color), LC-MS/MS and GC-MS toxicology instrumentation, FACS CANTO II and FC-500 flow cytometers, and karyotyping capabilities at up to 950 bands resolution using a Carl Zeiss Axio Imager Z2 automated microscope. The company holds three significant international accreditations: CAP accreditation from the College of American Pathologists (the only laboratory in Mexico with full CAP accreditation in microbiology testing), ISO 15189 accreditation from Entidad Mexicana de Acreditación (EMA), and NGSP Level 1 certification for HbA1c testing.

CARPERMOR operates a B2B professional services revenue model, with direct enterprise field sales targeting healthcare institutions, laboratories, occupational medicine providers, insurance integrators, physicians, and clinical researchers across six customer segments under a horizontal segmentation approach. Pricing is not publicly disclosed and services are delivered through direct advisory relationships positioning CARPERMOR as a strategic diagnostic partner. The company markets through a multi-channel approach including its corporate website (carpermor.com.mx), LinkedIn, Twitter, Instagram, YouTube, annual research conferences (XXVI Jornadas CARPERMOR in 2024), digital webinars and seminars, email newsletters, and educational blog content, and it also operates CarperNet, an online client portal for remote laboratory results access.

Grupo Diagnóstico Médico PROA S.A. de C.V firmographics

Firmographics
Name
Grupo Diagnóstico Médico PROA S.A. de C.V
Legal name
Grupo Diagnóstico Médico Proa, S.A. de C.V.
Website
https://carpermor.com.mx
Company type
Private
Founded year
1996
Operating status
Operating
Short description
Mexican clinical reference laboratory group operating the CARPERMOR brand with 23 analytical centers nationwide, delivering 2,600+ specialized diagnostic tests across nine specialties to hospitals, laboratories, occupational medicine clinics, physicians, and clinical researchers.
Ownership category
akta.pro rank

Grupo Diagnóstico Médico PROA S.A. de C.V industry classification

Industry
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
akta.pro secondary industries
Clinical Research & Trial Central Laboratories (HLAFAMAL), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

  • Clinical reference laboratory
  • Diagnostic testing services
  • Molecular diagnostics
  • Medical laboratory services
  • Pathology and cytogenetics

Where Grupo Diagnóstico Médico PROA S.A. de C.V is headquartered

Location

Headquarters

HQ city
Mexico City
HQ country
Mexico
HQ region
Latin America

Offices2 records

Markets served

Grupo Diagnóstico Médico PROA S.A. de C.V business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Clinical Laboratory Testing Services: Laboratory diagnostic services providing 2,600+ clinical studies across specialties including molecular biology, genetics, hematology, immunology, microbiology, and toxicology. Services delivered to hospitals, laboratories, occupational medicine clinics, and physicians.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Grupo Diagnóstico Médico PROA S.A. de C.V product offering

Product offering

Core offering

Grupo Diagnóstico Médico PROA S.A. de C.V. operates CARPERMOR, a Mexican clinical reference laboratory providing more than 2,600 specialized diagnostic studies across molecular biology, genetics, cytogenetics, hematology, immunology, microbiology, toxicology, histopathology and immunochemistry. Services are delivered through 23 analytical centers nationwide to hospitals, private laboratories, occupational medicine clinics, integrators/insurers, physicians, and clinical researchers, supported by CAP, ISO 15189 and NGSP Level 1 quality accreditations.

Product overview

CARPERMOR is a clinical reference laboratory operating as a single unified service with 23 analytical centers across Mexico. The portfolio comprises nine core specialty testing services: Clinical Laboratory Services (core offering), Toxicology and Instrumental Bioanalysis, Microbiology and Parasitology, Immunochemistry, Hematology and Flow Cytometry, Cytogenetics and Cytogenomics, Molecular Biology/Genetics/Genomics, Histopathology and Cytology, Immunology and Infectology, and Urinalysis. Together these specialties offer more than 2,600 diagnostic studies and tests, supported by a quality management system accredited by CAP and ISO 15189.

Differentiator

Problem solved

Functional benefit

Brands

  • CarperNet: Client portal for consulting laboratory results online
  • XXVI Journales CARPERMOR

Quantifiable outcome

  • 84+ million studies performed annually with quality assurance
  • +2 more outcomes

Companies that use Grupo Diagnóstico Médico PROA S.A. de C.V

Customer profile

Named customers6 records

Segments6 records

Grupo Diagnóstico Médico PROA S.A. de C.V technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Grupo Diagnóstico Médico PROA S.A. de C.V partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Grupo Diagnóstico Médico PROA S.A. de C.V competitors and assessment

Company assessment

Direct peers

  • LABIN / Laboratorio de Análisis Clínicos: Mexican clinical laboratory operator with multiple branches offering routine and specialized diagnostic testing. Comparable horizontal B2B/B2C model and multi-specialty menu.
  • Olarte y Akle (Grupo Diagnóstico Proa competitor): Mexican clinical reference lab group with multiple branches providing diagnostic testing to physicians, hospitals and patients. Comparable to CARPERMOR in geographic focus (Mexico), service mix and B2B go-to-market.
  • Laboratorios Chopo: One of Mexico's largest independent clinical laboratory chains, offering a broad test menu to walk-in and B2B customers nationwide. Closest direct competitor to CARPERMOR by service model, scale and target segments.
  • Laboratorios Polanco: Mexico-based clinical laboratory network with broad ambulatory and B2B testing services. Competes with CARPERMOR for physician referrals and hospital send-out work in the Mexican market.

Broad incumbents

  • Quest Diagnostics: U.S.-headquartered global reference lab with extensive esoteric testing, broad routine menu and B2B hospital/physician channels. Sets competitive benchmark on scale, automation and international accreditations that CARPERMOR emulates in Mexico.
  • Synlab Group: European-headquartered clinical reference laboratory operating in over 30 countries with broad routine and specialty menus. Comparable central-lab and clinical-research services model and accreditation profile.
  • Sonic Healthcare: Global medical diagnostics operator with national reference laboratory networks across multiple geographies. Comparable in providing accredited central-lab services to hospitals, physicians and occupational-medicine clients.
  • Laboratory Corporation of America (Labcorp): Large global clinical laboratory and diagnostics company with central-lab capabilities serving hospitals, physicians and clinical trials. Comparable in central-lab services for pharma research that CARPERMOR also pursues.
  • Eurofins Scientific: Global group with a strong clinical diagnostics arm offering reference lab and specialty testing across many countries. Relevant comparable for CARPERMOR's specialty testing (microbiology, genomics) and clinical trial central lab work.

Regional players

  • SRL Diagnostics: Large emerging-market clinical reference lab headquartered in India, serving physicians, hospitals and pharma sponsors with broad esoteric and routine testing. Comparable as an international (non-Mexico) reference lab peer pursuing similar growth drivers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Grupo Diagnóstico Médico PROA S.A. de C.V social profiles

Digital presence

Grupo Diagnóstico Médico PROA S.A. de C.V compliance and trust

Trust signal

Compliance3 records

Grupo Diagnóstico Médico PROA S.A. de C.V financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Grupo Diagnóstico Médico PROA S.A. de C.V leadership team

Management profile

Number of profiles

Grupo Diagnóstico Médico PROA S.A. de C.V subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Grupo Diagnóstico Médico PROA S.A. de C.V funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Grupo Diagnóstico Médico PROA S.A. de C.V M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Diagnóstico Médico PROA S.A. de C.V

What does Grupo Diagnóstico Médico PROA S.A. de C.V do?

Grupo Diagnóstico Médico PROA S.A. de C.V. operates CARPERMOR, a Mexican clinical reference laboratory providing more than 2,600 specialized diagnostic studies across molecular biology, genetics, cytogenetics, hematology, immunology, microbiology, toxicology, histopathology and immunochemistry. Services are delivered through 23 analytical centers nationwide to hospitals, private laboratories, occupational medicine clinics, integrators/insurers, physicians, and clinical researchers, supported by CAP, ISO 15189 and NGSP Level 1 quality accreditations.

Is Grupo Diagnóstico Médico PROA S.A. de C.V a public or private company?

Grupo Diagnóstico Médico PROA S.A. de C.V is a private company. It is currently operating.

When was Grupo Diagnóstico Médico PROA S.A. de C.V founded?

Grupo Diagnóstico Médico PROA S.A. de C.V was founded in 1996.

Where is Grupo Diagnóstico Médico PROA S.A. de C.V based?

Grupo Diagnóstico Médico PROA S.A. de C.V is headquartered in Mexico City, Mexico, in the Latin America region.

How does Grupo Diagnóstico Médico PROA S.A. de C.V make money?

One revenue line is on record: clinical Laboratory Testing Services.

Who are Grupo Diagnóstico Médico PROA S.A. de C.V's main competitors?

Direct peers on record are LABIN / Laboratorio de Análisis Clínicos, Olarte y Akle (Grupo Diagnóstico Proa competitor), Laboratorios Chopo and Laboratorios Polanco. Broad incumbents are Quest Diagnostics, Synlab Group, Sonic Healthcare, Laboratory Corporation of America (Labcorp) and Eurofins Scientific. SRL Diagnostics is listed as a regional player.

Does Grupo Diagnóstico Médico PROA S.A. de C.V have an API?

No public API is recorded for Grupo Diagnóstico Médico PROA S.A. de C.V.

What industry is Grupo Diagnóstico Médico PROA S.A. de C.V in?

Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales